Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Buy
19,621
+1,215
+7% +$21.7K ﹤0.01% 5160
2026
Q1
$350K Sell
18,406
-114,539
-86% -$2.21M ﹤0.01% 4408
2025
Q4
$2.18M Buy
132,945
+70,839
+114% +$1.25M ﹤0.01% 2341
2025
Q3
$1.17M Buy
62,106
+43,319
+231% +$777K ﹤0.01% 2601
2025
Q2
$379K Buy
+18,787
New +$325K ﹤0.01% 3005
2025
Q1
Sell
-22,779
Closed -$314K 3537
2024
Q4
$270K Buy
+22,779
New +$359K ﹤0.01% 3012

Other funds holding XP

IMC Chicago's XP Position: Q2 2026 in Review

IMC Chicago increased its XP (XP) stake by 6.6% in Q2 2026, buying an estimated $21.7K and bringing the position to 19,621 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #5160.

IMC Chicago first reported a position in XP in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.18M in Q4 2025. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • IMC Chicago held 19,621 shares of XP worth $319K as of Q2 2026.
  • IMC Chicago bought 1,215 XP shares in Q2 2026, an estimated $21.7K.
  • XP made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #5160 holding.
  • IMC Chicago first reported a position in XP in Q4 2024 and has held it in 6 quarters since.
  • IMC Chicago's XP position peaked at $2.18M in Q4 2025.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.